Global Health Stock Price - ₹1,417.30 | Healthcare Services

‌
‌
‌

Company insights, generated from the most recent coverage.

Q1 FY27 revenue surged 26.2% YoY to ₹1,326 Cr with EBITDA up 23.5% to ₹315 Cr. Adjusted profitability is growing despite flat PAT due to one-time income in prior year.
Noida hospital is rapidly approaching breakeven, a key de-risking factor for expansion. EBITDA loss narrowed sharply from ₹23.6 Cr to ₹4.9 Cr while revenue jumped to ₹85.5 Cr in Q1 FY27.
Board approved acquisition of a 79-bed Cancer Care Hospital in Indore, expanding capacity in the high-margin oncology segment adjacent to existing facility.

‌
‌
‌

The Quarter story

The two most recent quarterly results, compared side-by-side.

Global Health Ltd shows strong top-line growth and expanding capacity, though rising operational costs and debt are pressuring net margins.

Consolidated revenue grew from ₹10,308 Cr in Q1 FY26 to ₹13,041 Cr in Q1 FY27 over five quarters — strong top-line expansion

PAT margin declined from 15.1% in Q1 FY26 to 11.9% in Q1 FY27 over five quarters — bottom-line pressure

Total bed capacity expanded from 3,062 in Q1 FY26 to 3,737 in Q1 FY27 over five quarters — steady network scaling

Cost of materials consumed rose from ₹2,391 Cr in Q1 FY26 to ₹2,944 Cr in Q1 FY27 over five quarters — tracking higher treatment volumes

EBITDA rose from ₹2,553 Cr in Q1 FY26 to ₹3,153 Cr in Q1 FY27 over five quarters — solid operational profitability

Employee benefits expense increased from ₹3,852 Cr in Q1 FY26 to ₹5,136 Cr in Q1 FY27 over five quarters — reflecting headcount growth

Outpatient volumes surged from 818,815 in Q1 FY26 to 11,00,928 in Q1 FY27 over five quarters — robust clinic demand

Finance costs climbed from ₹138 Cr in Q1 FY26 to ₹267 Cr in Q1 FY27 over five quarters — higher debt servicing obligations

OPD pharmacy revenue increased from ₹404 Cr in Q1 FY26 to ₹609 Cr in Q1 FY27 over five quarters — successful retail monetization

Occupied bed days dropped from 161,429 in Q4 FY26 to 79,401 in Q1 FY27 quarter-on-quarter — partial quarter and seasonal utilization

‌
‌
‌

In the news

Delhi Master Plan 2047 boosts Max, Fortis, Medanta stocks

Global Health shares fall 2.17% despite strong Q1 performance

Trade Spotlight: 17 stocks with bullish technical setups for June 29

HDFC MF buys 10L Global Health shares for ₹130 cr

Global Health, BEL See Massive Volume Surge on BSE

HDFC MF buys ₹122 cr stake in Global Health from co-founder

Global Health gets buy ratings from Prabhudas Lilladher and Anand Rathi

Global Health Q4FY26 Results Show Strong Growth Visibility

Global Health Q4 net profit surges 42% to ₹144 crore

GK Energy Upgraded to Buy Amid India's Economic Growth

Global Health to invest ₹550 cr in 400-bed Varanasi hospital

Anand Rathi recommends Global Health buy with Rs 1450 target

Motilal Oswal Sets Global Health Target at ₹1375

Prabhudas Lilladher Recommends Global Health Buy at Rs 1375 Target

Medanta Q3 profit drops 33% on Noida losses, revenue up 19%

Global Health